Mianserin
| Mianserin | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 264.4 g/mol [1] |
| Solubility | 2.32e-01 g/L [1] |
| Predicted LogP | 3.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C18H20N2 [1] |
| IUPAC name | 5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene [1] |
| SMILES | CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42 [1] |
| InChI | InChI=1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3 [1] |
| InChIKey | UEQUQVLFIPOEMF-UHFFFAOYSA-N [1] |
(Redirected from (R)-Mianserin)
Mianserin (also known as Mianserine, Mianserina, Mianserinum, Tolvon, 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine, Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, J16.389I, Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, 1,2,3,4,10,14b-hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine or 1,2,3,4,10,14B-hexahydro-2-methyldibenzo(c,f)-pyrazino(1,2-a)azepine) is a
Chemistry
Stereochemistry []
Mianserin is a racemic mixture of the enantiomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
Pharmacology
ATC Classification
Metabolism
Subjective effects []
See also []
External links []
- Mianserin (Wikipedia)
- Mianserin (DrugBank)
- Mianserin / (S)-Mianserin / (R)-Mianserin (PubChem)
- Mianserin / (S)-Mianserin / (R)-Mianserin (ChEMBL)
- Mianserin (ChEBI)
- Mianserin / (S)-Mianserin / (R)-Mianserin (Common Chemistry)
- Mianserin (HMDB)
- Mianserin (KEGG)
- Mianserin / (S)-Mianserin / (R)-Mianserin (UNII)
- Mianserin / (S)-Mianserin / (R)-Mianserin (EPA DSSTox)
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4184, Mianserin. Accessed July 21, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/4184